Arteriosclerosis
Not recruitingStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
- Disease:Arteriosclerosis
- Substances:Inclisiran
Hungary- Participants:18–64 years · 65+ years
- Substances:Inclisiran
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Hungary63 clinical trials in Balatonfured, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
HungaryThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on heart failure prevention and treatment of atherosclerotic cardiovascular disease. Studies are evaluating innovative therapies for patients with various cardiac conditions.
Several trials are investigating new combinations of medications to reduce cardiovascular events and improve patient outcomes.
Innovative research targeting type 2 diabetes and obesity, with studies evaluating new therapeutic approaches for weight management and metabolic health improvement.
Multiple trials are exploring combined approaches to treating metabolic disorders and their complications.
Advanced clinical research in atopic dermatitis treatment, focusing on innovative therapies for moderate to severe cases. Studies are evaluating both standalone treatments and combination approaches.
Research includes long-term safety and efficacy evaluations of new therapeutic options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.